Your browser doesn't support javascript.
loading
Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer.
Puszkiel, Alicja; Arellano, Cécile; Vachoux, Christelle; Evrard, Alexandre; Le Morvan, Valérie; Boyer, Jean-Christophe; Robert, Jacques; Delmas, Caroline; Dalenc, Florence; Debled, Marc; Venat-Bouvet, Laurence; Jacot, William; Dohollou, Nadine; Bernard-Marty, Chantal; Laharie-Mineur, Hortense; Filleron, Thomas; Roché, Henri; Chatelut, Etienne; Thomas, Fabienne; White-Koning, Melanie.
Afiliación
  • Puszkiel A; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Arellano C; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Vachoux C; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Evrard A; Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire Nîmes-Carémeau, Nîmes, France.
  • Le Morvan V; IRCM, Inserm, Université de Montpellier, ICM, Montpellier, France.
  • Boyer JC; Inserm U1218, Université de Bordeaux, Bordeaux, France.
  • Robert J; Institut Bergonié, Bordeaux, France.
  • Delmas C; Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire Nîmes-Carémeau, Nîmes, France.
  • Dalenc F; Inserm U1218, Université de Bordeaux, Bordeaux, France.
  • Debled M; Institut Bergonié, Bordeaux, France.
  • Venat-Bouvet L; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Jacot W; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.
  • Dohollou N; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Bernard-Marty C; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.
  • Laharie-Mineur H; Institut Bergonié, Bordeaux, France.
  • Filleron T; Centre Hospitalier Universitaire Dupuytren, Limoges, France.
  • Roché H; Institut du Cancer de Montpellier, Montpellier, France.
  • Chatelut E; Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France.
  • Thomas F; Clinique Pasteur - ONCORAD, Toulouse, France.
  • White-Koning M; Clinique Tivoli-Ducos, Bordeaux, France.
Clin Pharmacol Ther ; 109(5): 1244-1255, 2021 05.
Article en En | MEDLINE | ID: mdl-33047329
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Tamoxifeno / Neoplasias de la Mama / Citocromo P-450 CYP2D6 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polimorfismo Genético / Tamoxifeno / Neoplasias de la Mama / Citocromo P-450 CYP2D6 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2021 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Estados Unidos